[go: up one dir, main page]

SK10332003A3 - Farmaceutický prostriedok na inhibíciu rastu nádorov a/alebo nádorových buniek - Google Patents

Farmaceutický prostriedok na inhibíciu rastu nádorov a/alebo nádorových buniek Download PDF

Info

Publication number
SK10332003A3
SK10332003A3 SK1033-2003A SK10332003A SK10332003A3 SK 10332003 A3 SK10332003 A3 SK 10332003A3 SK 10332003 A SK10332003 A SK 10332003A SK 10332003 A3 SK10332003 A3 SK 10332003A3
Authority
SK
Slovakia
Prior art keywords
taxane
tumor
cells
formula
dose
Prior art date
Application number
SK1033-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Joseph Fargnoli
William C. Rose
Pamela Trail
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of SK10332003A3 publication Critical patent/SK10332003A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Carpets (AREA)
SK1033-2003A 2001-02-28 2002-02-26 Farmaceutický prostriedok na inhibíciu rastu nádorov a/alebo nádorových buniek SK10332003A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27194401P 2001-02-28 2001-02-28
PCT/US2002/005971 WO2002067928A2 (en) 2001-02-28 2002-02-26 Metronomic dosing of taxanes for inhibiting tumor growth

Publications (1)

Publication Number Publication Date
SK10332003A3 true SK10332003A3 (sk) 2005-03-04

Family

ID=23037749

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1033-2003A SK10332003A3 (sk) 2001-02-28 2002-02-26 Farmaceutický prostriedok na inhibíciu rastu nádorov a/alebo nádorových buniek

Country Status (31)

Country Link
EP (1) EP1372636B1 (xx)
JP (1) JP2004538253A (xx)
KR (1) KR20030086276A (xx)
CN (1) CN1533273A (xx)
AR (1) AR033609A1 (xx)
AT (1) ATE331511T1 (xx)
BG (1) BG108167A (xx)
BR (1) BR0207519A (xx)
CA (1) CA2439299A1 (xx)
CY (1) CY1105468T1 (xx)
CZ (1) CZ20032232A3 (xx)
DE (2) DE60212813T2 (xx)
DK (1) DK1372636T3 (xx)
EE (1) EE200300413A (xx)
ES (1) ES2211374T3 (xx)
HR (1) HRP20030775A2 (xx)
HU (1) HUP0402115A2 (xx)
IL (1) IL157356A0 (xx)
IS (1) IS6924A (xx)
MX (1) MXPA03007655A (xx)
NO (1) NO20033809L (xx)
PE (1) PE20020955A1 (xx)
PL (1) PL373376A1 (xx)
PT (1) PT1372636E (xx)
RU (1) RU2003129233A (xx)
SK (1) SK10332003A3 (xx)
TR (1) TR200400375T3 (xx)
UY (1) UY27185A1 (xx)
WO (1) WO2002067928A2 (xx)
YU (1) YU66603A (xx)
ZA (1) ZA200306450B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750246B1 (en) 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
US20080063699A1 (en) * 2003-10-15 2008-03-13 Michael Teifel Method of Administering Cationic Liposomes Comprising an Active Drug
AU2006243337B2 (en) 2005-05-04 2011-09-29 Syncore Biotechnology Co., Ltd Method of administering a cationic liposomal preparation comprising paclitaxel
ES2609388T3 (es) 2006-03-22 2017-04-20 Syncore Biotechnology Co., Ltd Tratamiento del cáncer de mama triple negativo a receptores

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100615783B1 (ko) * 1997-05-27 2006-08-25 아이박스 리서치 인코포레이티드 탁산 치료를 받고 있는 인체를 제외한 포유동물의 과민증 또는 알러지 반응을 경감시키기 위한 방법 및 약학적 키트
US6750246B1 (en) * 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
US6362217B2 (en) * 2000-03-17 2002-03-26 Bristol-Myers Squibb Company Taxane anticancer agents

Also Published As

Publication number Publication date
KR20030086276A (ko) 2003-11-07
ATE331511T1 (de) 2006-07-15
RU2003129233A (ru) 2005-02-10
BR0207519A (pt) 2005-03-08
CA2439299A1 (en) 2002-09-06
ES2211374T1 (es) 2004-07-16
CN1533273A (zh) 2004-09-29
IS6924A (is) 2003-08-22
PL373376A1 (en) 2005-08-22
DE60212813T2 (de) 2007-01-18
CY1105468T1 (el) 2010-04-28
UY27185A1 (es) 2002-09-30
DK1372636T3 (da) 2006-11-06
NO20033809L (no) 2003-10-23
DE60212813D1 (de) 2006-08-10
ZA200306450B (en) 2004-11-19
PE20020955A1 (es) 2002-10-30
AR033609A1 (es) 2003-12-26
YU66603A (sh) 2006-08-17
HUP0402115A2 (hu) 2005-02-28
CZ20032232A3 (en) 2004-06-16
PT1372636E (pt) 2006-09-29
JP2004538253A (ja) 2004-12-24
ES2211374T3 (es) 2007-03-01
EP1372636A2 (en) 2004-01-02
WO2002067928A2 (en) 2002-09-06
NO20033809D0 (no) 2003-08-27
HRP20030775A2 (en) 2005-02-28
DE02723255T1 (de) 2004-07-15
TR200400375T3 (tr) 2004-04-21
WO2002067928A3 (en) 2003-10-09
EE200300413A (et) 2003-12-15
EP1372636B1 (en) 2006-06-28
IL157356A0 (en) 2004-02-19
MXPA03007655A (es) 2003-12-04
BG108167A (en) 2004-09-30

Similar Documents

Publication Publication Date Title
EP3421039B1 (en) Drug for cancer therapy characterized by administering combination between axl inhibitor and immune checkpoint inhibitor
ES2700450T3 (es) Combinación terapéutica y uso de anticuerpos antagonistas de DLL4 y agentes antihipertensores
EP3673907A1 (en) Pharmaceutical for cancer treatment including ax1 inhibitor as an effective component
US20220313642A1 (en) Tyrosine derivatives and compositions comprising them
JP2008509948A5 (xx)
JP2007538105A (ja) Ｇｓｔ活性化抗癌化合物による治療による別の抗癌療法の増感および／または別の抗癌療法の副作用の改善
US20040143004A1 (en) Metronomic dosing of taxanes
EP3911416B1 (en) Substituted quinazolines as nlrp3 modulators, for use in the treatment of cancer
CN109922834B (zh) 用于治疗癌症的卟啉化合物和组合物
CA3045110A1 (en) Tyrosine derivatives and compositions comprising them
US20240398823A1 (en) Dual inhibitor of histone deacetylase 6 and heat shock protein 90
SK10332003A3 (sk) Farmaceutický prostriedok na inhibíciu rastu nádorov a/alebo nádorových buniek
WO2019055064A9 (en) Compositions and methods for preventing and treating heterotopic ossification and pathologic calcification
WO2024145245A2 (en) Alpha-v-beta-8 integrin inhibitors and uses thereof
EP4378473A1 (en) Her2 vaccine composition
RU2697551C2 (ru) Новые производные peg
TW202011946A (zh) 以bet抑制劑及蛋白酶體抑制劑之組合療法
WO2014191989A1 (en) Conjugate of a taxane and biotin and uses thereof
KR20220054853A (ko) 치료 방법
AU2002254048A1 (en) Metronomic dosing of taxanes for inhibiting tumor growth
JP6596624B2 (ja) 抗腫瘍剤
EP1623706A2 (en) Metronomic dosing of taxanes for inhibiting tumor growth
RU2822394C1 (ru) Способы лечения
TW201513849A (zh) 藉由合成之帕那司托（ｐａｎａｘｙｔｒｉｏｌ）類似物之毒性下降

Legal Events

Date Code Title Description
FC9A Refused patent application